India one step closer to approving weight-loss drug tirzepatide: What is it? How does it work?
8 months, 2 weeks ago

India one step closer to approving weight-loss drug tirzepatide: What is it? How does it work?

Firstpost  

Eli Lilly, the pharmaceutical company, has received the first approval for the sale of its blockbuster drug Tirzepatide in India. Here’s what we know about this ‘game-changing’ medication A box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes made by Lilly is seen at Rock Canyon Pharmacy in Provo, Utah. Last week, the apex drug regulator’s, Central Drug Standard Control Organisation, subject expert committee gave the green light to Eli Lilly’s tirzepatide — the active ingredient in the company’s Mounjaro and Zepbound. However, Elli Lilly told Economic Times: “The apex drug regulator has so far given a go-ahead for its import and marketing for diabetes and not for weight loss. An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City.

India Weight Loss Loss Drugs Diabetes Weight Drug Reuters Fda Novo Nordisk Wegovy Zepbound Mounjaro Type 2 Diabetes Eli Lilly Eli Tirzepatide  step  weightloss  drug  does  weight  work  mounjaro  india  tirzepatide  closer  approving  eli  zepbound  loss  diabetes  drugs

History of this topic

Mounjaro arrives in India: Game-changer or not?
Trending News
5 days, 9 hours ago

Mounjaro arrives in India: Game-changer or not?

Hindustan Times  

The Ozempic craze is not yet over. “Mounjaro’s ability to regulate appetite, improve insulin sensitivity, and reduce liver sugar production sets it apart from other diabetes medications,” informs Dr Sharwari Dabhade, endocrinologist at Madhukar Rainbow Children’s Hospital. "Studies show that Mounjaro can support weight loss even in people without diabetes. “Regular monitoring of a patient is important while on this …

'Ozempic-like' weight loss drug Mounjaro creates buzz amid India launch: Price per month, availability, pros and cons
5 days, 11 hours ago

'Ozempic-like' weight loss drug Mounjaro creates buzz amid India launch: Price per month, availability, pros and cons

Hindustan Times  

Amy Schumer has praised weight loss drug Mounjaro after a not-so-great experience with Wegovy years prior. Originally developed for type 2 diabetes, it has shown remarkable weight loss benefits — helping overweight individuals without diabetes lose up to 20–25 percent of their body weight, while those with diabetes experience around 15 percent reduction,” Dr Rajiv Kovil says. Dr Aparna Govil …

Mounjaro, the injection to fight type-2 diabetes, draws global attention as new weight loss drug
1 week, 3 days ago

Mounjaro, the injection to fight type-2 diabetes, draws global attention as new weight loss drug

Firstpost  

Mounjaro, an injectable medication designed to support weight loss, works by imitating the effects of two natural hormones, GLP-1 and GIP, which help control appetite, blood sugar levels, and digestion A box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and made by Lilly is seen at Rock Canyon Pharmacy in Provo, Utah. Pharmaceutical joint Eli …

Mounjaro enters India as weight-loss drug, but doctors warn against misuse
1 week, 3 days ago

Mounjaro enters India as weight-loss drug, but doctors warn against misuse

India Today  

The much-awaited anti-diabetes and weight-loss drug Mounjaro, developed by US pharmaceutical giant Eli Lilly, was launched in India on March 20. Dr. Ashutosh Goyal, Senior Consultant Endocrinologist at Paras Health Gurugram, called Mounjaro’s availability in India a “big step forward” in diabetes and obesity management. "By combining pharmaceuticals with personalised care, we can help improve patient outcomes and mitigate the …

Blockbuster weight-loss drug Mounjaro comes to India: How does it work?
1 week, 4 days ago

Blockbuster weight-loss drug Mounjaro comes to India: How does it work?

Firstpost  

The popular anti-obesity drug Mounjaro has finally been launched in India. The development comes after Eli Lilly received approval from India’s Central Drugs Standard Control Organisation. Eli Lilly has received approval from India’s Central Drugs Standard Control Organisation to launch Mounjaro. ‘First of its kind’ “It is a first-of-its-kind treatment for obesity, overweight, and type 2 diabetes that activates both …

Obesity and diabetes management drug launched in India by American pharma company Eli Lilly
Trending News
1 week, 4 days ago

Obesity and diabetes management drug launched in India by American pharma company Eli Lilly

The Hindu  

American pharmaceutical major Eli Lilly and Company on Thursday launched its diabetes and obesity management drug Mounjaro in India. Novo Nordisk’s oral semaglutide tablet, Rybelsus, launched in India in January 2022, has already captured nearly 65% of the anti-obesity drug market along with other weight loss medications, including dulaglutide, orlistat, and liraglutide. Obesity, a chronic relapsing disease and a major …

Mounjaro: Eli Lilly launches popular weight-loss drug in India
Top News
1 week, 4 days ago

Mounjaro: Eli Lilly launches popular weight-loss drug in India

Hindustan Times  

Eli Lilly and Company on Thursday announced the launch of its globally popular weight-loss injectable drug, Mounjaro, in India. Mounjaro is also indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,” read the company statement. Chemically known as Tirzepatide, the drug was evaluated in two robust global clinical development programs: …

Mounjaro, popular weight-loss drug, launched in India. Here's how much it costs
1 week, 4 days ago

Mounjaro, popular weight-loss drug, launched in India. Here's how much it costs

India Today  

Popular anti-diabetes and obesity drug Mounjaro has been launched in India, by the US-based pharmaceutical giant Eli Lilly, after receiving marketing authorisation from India's drug regulator - the Central Drugs Standard Control Organisation. The prescription drug is recommended for: Adults with obesity Adults who are overweight and have other health problems related to weight Adults with type 2 diabetes to …

Medicine, not miracle drug: Top pharma executive busts weight-loss myths
3 weeks, 3 days ago

Medicine, not miracle drug: Top pharma executive busts weight-loss myths

India Today  

Weight-loss drug is not a magic pill, Novo Nordisk India’s Vikrant Shrotriya said while speaking at a session on obesity treatments at the India Today Conclave 2025. Shrotriya, who is also the Corporate Vice President of Novo Nordisk India, highlighted the importance of making lifestyle and diet changes to combat obesity as he pushed back against tags such as "miracle …

Why don't celebrities admit to taking weight-loss medicine? Expert answers at India Today Conclave
3 weeks, 3 days ago

Why don't celebrities admit to taking weight-loss medicine? Expert answers at India Today Conclave

India Today  

Many celebrities who have undergone dramatic transformations have avoided admitting to using weight loss drugs, despite its growing popularity. Addressing this reluctance, Vikrant Shrotriya, Corporate Vice President & Managing Director of Novo Nordisk India, said, "They just want to pat their back that they have fantastic genes. Watch the full India Today Conclave 2025 here During a session on obesity …

Weight loss drugs linked to dozens of deaths
1 month, 1 week ago

Weight loss drugs linked to dozens of deaths

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Ozempic play: Mankind Pharma in the fray for weight-loss drugs
1 month, 1 week ago

Ozempic play: Mankind Pharma in the fray for weight-loss drugs

Live Mint  

Mankind Pharma, India’s fourth largest drugmaker by domestic sales, is setting its sights on anti-obesity drugs like Semaglutide, better known by brand names Ozempic and Wegovy, which goes off-patent early next year. “Obesity is the market everybody wants to look at, it's a very, very big market opening up…we are no exception to that," Atish Majumdar, senior president at Mankind …

Eli Lilly likely to launch weight loss & anti-diabetes drug in India: Is it safe to consume?
1 month, 4 weeks ago

Eli Lilly likely to launch weight loss & anti-diabetes drug in India: Is it safe to consume?

Live Mint  

US-based pharmaceutical company Eli Lilly is planning to launch Mounjaro, an anti-diabetes and weight loss drug in India by 2025 after regulatory approvals, reported News18 citing officials from the company. We haven’t yet finalised the pricing strategy for the Tirzapedite, but our pricing will reflect the medicine’s efficacy and the fact that it improves overall health and reduces the economic …

Retatrutide outperforms Ozempic in weight loss, new study finds
2 months, 3 weeks ago

Retatrutide outperforms Ozempic in weight loss, new study finds

India Today  

The new experimental weight loss drug, Retatrutide, is showing promising results. The Study Findings Researchers from McGill University reviewed 26 clinical trials involving nearly 15,500 participants to assess the effectiveness of various weight loss drugs for obese adults without diabetes. In comparison, semaglutide, the active ingredient in popular drugs like Ozempic and Wegovy, showed a weight loss of up to …

It’s getting harder to claim success with weight reduction drugs
2 months, 4 weeks ago

It’s getting harder to claim success with weight reduction drugs

Live Mint  

In a new study, an experimental obesity drug from Novo Nordisk, CagriSema allowed people to lose more than 20% of their body weight, on average, a result that caused the Danish company’s stock price to fall by as much as 29%. CagriSema is a combination of the GLP-1 agonist semaglutide, the ingredient found in Novo’s Ozempic and Wegovy, and cagrilintide, …

MATT RIDLEY: Move over, Ozempic: Why an astonishing new class of weight-loss drugs will soon end obesity FOR EVER - and here are the other surprising illnesses they could treat
3 months ago

MATT RIDLEY: Move over, Ozempic: Why an astonishing new class of weight-loss drugs will soon end obesity FOR EVER - and here are the other surprising illnesses they could treat

Daily Mail  

Imagine if you could eat your fill on Christmas Day then dial down your appetite for January. The past year has seen the rise of myriad weight-loss drugs that are getting better and achieving results where decades of hectoring and dieting have failed – in yet another miracle of biomedical science. Yes cancer, dementia and anxiety are on the rampage; …

Weight-loss drugs better for slimming down than dieting, says expert
3 months ago

Weight-loss drugs better for slimming down than dieting, says expert

Daily Mail  

Those planning to slim down with a diet in the New Year may want to think again. University of Ottawa Professor Yoni Freedhoff, who has spent decades studying the best ways to slim down, compared data from lifestyle-based weight-loss trial Look Ahead to two trials of new slimming jabs. Participants in the Look Ahead trial stuck to an ‘intensive’ diet …

Competition will make weight-loss drugs better, cheaper and bigger
3 months, 1 week ago

Competition will make weight-loss drugs better, cheaper and bigger

Live Mint  

Among the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for hawking remedies for erectile dysfunction and hair loss. Patrik Jonsson, head of the division at Eli Lilly that is responsible for weight-loss drugs, says that the level of competition is something he has never experienced before. In China nearly half …

Weight-loss drugs: A game changer for India’s top pharma companies
3 months, 1 week ago

Weight-loss drugs: A game changer for India’s top pharma companies

Live Mint  

Over 650 million adults globally suffer from obesity, and this number is only expected to rise. India’s rising players in the GLP-1 market Indian pharmaceutical giants like Sun Pharma, Cipla, Dr. Reddy’s, Natco Pharma, and Lupin are in a fierce race to bring obesity drugs to the Indian market. Cipla: Entering the market with generics Cipla, one of India’s most …

Eli Lilly new trial is all about the battle to be best weight-loss drug zepbound and wegovy
3 months, 3 weeks ago

Eli Lilly new trial is all about the battle to be best weight-loss drug zepbound and wegovy

India Today  

In a study trial, pharmaceutical giant Eli Lilly's weight-loss drug Zepbound showed better results than another pharmaceutical company, Novo Nordisk's weight-loss drug Wegovy. The trial, called SURMOUNT-5, compared Zepbound to Wegovy, which is a mono GLP-1 receptor agonist in adults living with obesity without diabetes. The results showed Zepbound delivering a remarkable 47% greater relative weight loss compared to Wegovy, …

Weight-loss meds go head-to-head in new study. One was significantly more effective, drugmaker says
3 months, 3 weeks ago

Weight-loss meds go head-to-head in new study. One was significantly more effective, drugmaker says

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Zepbound tops Wegovy for weight loss in Eli Lilly study
3 months, 3 weeks ago

Zepbound tops Wegovy for weight loss in Eli Lilly study

Associated Press  

Share Share Copy Link copied Email Facebook X Reddit LinkedIn Pinterest Flipboard Print Shares of Eli Lilly climbed Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped patients shed more pounds than Wegovy from rival Novo Nordisk. Lilly said patients taking Zepbound lost about 20% of their weight on average compared to nearly 14% …

Eli Lilly’s Zepbound beats Novo Nordisk’s Wegovy in first head-to-head study
3 months, 3 weeks ago

Eli Lilly’s Zepbound beats Novo Nordisk’s Wegovy in first head-to-head study

Live Mint  

In the first head-to-head test, Eli Lilly’s Zepbound obesity drug helped people lose significantly more weight than its main competitor, Novo Nordisk’s Wegovy. The details People taking Zepbound lost 20.2% of their body weight on average after 72 weeks of treatment in the Lilly- That translated into an average 50-pound loss for people who took Zepbound, while Wegovy users lost …

Weight loss drug battle heats up as Wegovy beaten in head-to-head trial
3 months, 3 weeks ago

Weight loss drug battle heats up as Wegovy beaten in head-to-head trial

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy A rival drug company is celebrating results claiming its drug helps …

Wegovy/Mounjaro: The UK thinks weight loss drugs could ease unemployment. Experts say that’s a fantasy
Trending News
4 months, 2 weeks ago

Wegovy/Mounjaro: The UK thinks weight loss drugs could ease unemployment. Experts say that’s a fantasy

CNN  

London CNN — Weight loss drugs such as Wegovy and Ozempic have been hailed worldwide as revolutionary for medicine. British Prime Minister Keir Starmer has said that his government needs to “think differently” about how to reduce pressure on the country’s national health care system, overburdened amid staffing shortages and funding pressures. Tom Little/Reuters The government trial studying links between …

First Mounjaro death in the UK: Nurse's death is directly linked to NHS-approved weight loss jab after 58-year-old fell ill taking two low-dose injections
4 months, 3 weeks ago

First Mounjaro death in the UK: Nurse's death is directly linked to NHS-approved weight loss jab after 58-year-old fell ill taking two low-dose injections

Daily Mail  

A nurse's death has been linked to her taking a weight-loss drug that was approved for use on the NHS. Susan McGowan, 58, from Lanarkshire, died from multiple organ failure, septic shock and pancreatitis after taking two low-dose injections of tirzepatide, known under the brand name Mounjaro. Earlier this year it was revealed the medicines watchdog received reports of ten …

Ozempic, Wegovy considered ‘available’ after more than 2 years in shortage
5 months ago

Ozempic, Wegovy considered ‘available’ after more than 2 years in shortage

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Influencers are being offered tens of thousands of dollars to hawk weight-loss drugs
5 months ago

Influencers are being offered tens of thousands of dollars to hawk weight-loss drugs

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Influencers have been offered tens …

Wegovy weight loss: The science and the hype of supplements
5 months, 3 weeks ago

Wegovy weight loss: The science and the hype of supplements

The Hindu  

Published : Oct 04, 2024 18:39 IST - 5 MINS READ It was sometime during the COVID-19 pandemic when Wegovy and Ozempic hit mainstream awareness. When used as a weight loss medication, Wegovy is only recommended “as an adjunct to diet and exercise to reduce weight in patients who are very obese,” Ward told DW. But the side effects mean …

NHS approved weight loss jab makes women lose more weight than men, analysis finds
6 months, 2 weeks ago

NHS approved weight loss jab makes women lose more weight than men, analysis finds

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Eli Lilly sanguine about China market
7 months ago

Eli Lilly sanguine about China market

China Daily  

Eli Lilly logo is shown on one of the company's offices in San Diego, California, US, Sept 17, 2020. Eli Lilly said people who are overweight or those who face obesity issues face social stigma every day and that the drugmaker aims to improve the quality of their lives. "The commonly held view that their weight is somehow their own …

Eli Lilly sanguine about China market
7 months ago

Eli Lilly sanguine about China market

China Daily  

Eli Lilly logo is shown on one of the company's offices in San Diego, California, US, Sept 17, 2020. Eli Lilly said people who are overweight or those who face obesity issues face social stigma every day and that the drugmaker aims to improve the quality of their lives. "The commonly held view that their weight is somehow their own …

The science of tirzepatide, touted as a game-changing weight loss drug
8 months, 1 week ago

The science of tirzepatide, touted as a game-changing weight loss drug

Hindustan Times  

Indians will soon have access to a new drug that targets obesity and diabetes, two diseases, which are widely prevalent among our population. They stimulate the release of insulin, and help increase insulin sensitivity in adipose and skeletal tissue,” said RNV Krishna Deepak, a computational structural biologist at Azim Premji University, Bengaluru. “Tirzepatide has received marketing authorisation for type-2 diabetes …

India to finally approve weight loss drug tirzepatide: Here's how it works
8 months, 2 weeks ago

India to finally approve weight loss drug tirzepatide: Here's how it works

India Today  

The subject expert committee under India's apex drug regulator, the Central Drug Standard Control Organisation, has given a green light to pharmaceutical giant Eli Lilly's tirzepatide, an active ingredient in their blockbuster drugs Mounjaro and Zepbound. It is a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, which means it mimics the effects of these naturally occurring hormones to …

Wegovy weight-loss drug OK'd in China
9 months ago

Wegovy weight-loss drug OK'd in China

China Daily  

FILE PHOTO: A view shows the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Danish drugmaker Novo Nordisk said Tuesday that its injectable weight-loss drug Wegovy has been approved in China, where the proportion of overweight and obese adults reached almost 51 percent of the country's 1.4 billion people …

Wegovy weight-loss drug OK'd in China
9 months ago

Wegovy weight-loss drug OK'd in China

China Daily  

By AI HEPING in New York | chinadaily.com.cn | Updated: 2024-06-26 14:54 FILE PHOTO: A view shows the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Danish drugmaker Novo Nordisk said Tuesday that its injectable weight-loss drug Wegovy has been approved in China, where the proportion of overweight and …

WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs
9 months, 1 week ago

WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs

Associated Press  

The World Health Organization and drugmaker Eli Lilly and Co. are warning people to be wary of fake versions of popular weight-loss and diabetes medicines. WHO said Thursday that it has fielded several reports of fake semaglutide — the active ingredient in Novo Nordisk’s Wegovy and Ozempic — in all geographic regions of the world since 2022. Lilly said in …

Revolutionary weight-loss jab Tirzepatide - which is sold under the name Mounjaro - could save patients from life-threatening liver failure, study finds
9 months, 3 weeks ago

Revolutionary weight-loss jab Tirzepatide - which is sold under the name Mounjaro - could save patients from life-threatening liver failure, study finds

Daily Mail  

A revolutionary weight-loss jab could save patients from life-threatening liver failure, a study has discovered. Tirzepatide, sold under the name Mounjaro, is an injectable anti-obesity drug that suppresses appetite by artificially activating the hormones that make you feel full – much like popular jabs Ozempic and Wegovy. More than half of patients with fatty liver disease, often triggered by obesity, …

The Taste with Vir: Will weight-loss drugs finish off the diet business?
9 months, 3 weeks ago

The Taste with Vir: Will weight-loss drugs finish off the diet business?

Hindustan Times  

Do you still talk about diets? The new drugs make the pleasure centres feel satiated much earlier than before; say, halfway through the sort of meal you would have completed in the old days. But now, for reasons I can’t fully explain, the branded diets are less popular and diet books sell much less. For years, the modern diet industry …

So, you’ve lost weight using Wegovy. What happens next?
10 months, 3 weeks ago

So, you’ve lost weight using Wegovy. What happens next?

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Do weight loss drugs work for diet industry built on eating less and exercising more?
11 months ago

Do weight loss drugs work for diet industry built on eating less and exercising more?

Hindustan Times  

Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his 30s to as high as 220. Do weight loss drugs work for diet industry built on eating less and exercising more? He's lost 30 pounds, and has started eating healthier food and exercising — the habits behind many commercial …

What do weight loss drugs mean for a diet industry built on eating less and exercising more?
11 months ago

What do weight loss drugs mean for a diet industry built on eating less and exercising more?

Associated Press  

NEW YORK — Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his 30s to as high as 220. He’s lost 30 pounds, and has started eating healthier food and exercising — the habits behind many commercial diet plans and decades of conventional wisdom on sustainable weight loss. “This …

How do Ozempic and other weight-loss drugs work? | In Focus podcast
1 year ago

How do Ozempic and other weight-loss drugs work? | In Focus podcast

The Hindu  

Weight-loss drugs including Ozempic, Wegovy and Mounjaro have been making headlines across the world for weight loss; celebrities including Oprah Winfrey and Elon Musk have spoken about using them to quickly and drastically lose weight. First approved for diabetes treatment, these drugs, which consist of semaglutide – are available in tablet and injectable form. While the tablet form was approved …

Weight-loss drugs like Wegovy are meant for long-term use. Some patients want to stop
1 year ago

Weight-loss drugs like Wegovy are meant for long-term use. Some patients want to stop

Associated Press  

Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a new dilemma: What happens if they stop taking them? “To me, it’s a help, it’s an aid,” said Donna Cooper, 62, of Front Royal, Virginia, who lost nearly 40 pounds in nine months using Wegovy along with diet and exercise. …

The tale of ‘have money, buy miracle drug’
1 year ago

The tale of ‘have money, buy miracle drug’

The Hindu  

For almost every week in the last few months, newspapers have been publishing articles about the use of ‘magic injections that guarantee weight loss’. However, many of the articles promoting these drugs fail to mention that this weight loss drug has not been approved for sale in India but is being administered by doctors to patients who are mostly affluent. …

Weight loss medications for obesity: Boon or a bane?
1 year ago

Weight loss medications for obesity: Boon or a bane?

India TV News  

Obesity, characterised by excessive fat accumulation that presents a health risk, is a significant concern in India. Weight Loss Medications in India To combat obesity, many individuals turn to weight loss medications. Weight loss medications in India primarily target different aspects of metabolism and appetite regulation to induce weight loss. Comprehensive Strategies for Combatting Obesity In addition to weight loss …

Eli Lilly Obesity Drug In India Likely Next Year: Report
1 year, 1 month ago

Eli Lilly Obesity Drug In India Likely Next Year: Report

ABP News  

Eli Lilly, the renowned US drugmaker, is gearing up to introduce its widely acclaimed diabetes medication, Mounjaro, along with its successful obesity treatment, to the Indian market as early as next year. With soaring obesity rates, particularly among women, and the second-highest number of individuals with type-2 diabetes globally, India presents an enticing opportunity for pharmaceutical companies. According to Reuters, …

Drugs like Ozempic and Wegovy could boost the US economy by a trillion dollars, Goldman Sachs says
1 year, 1 month ago

Drugs like Ozempic and Wegovy could boost the US economy by a trillion dollars, Goldman Sachs says

Salon  

More Americans taking popular medications used for weight loss, including Ozempic and Wegovy, could benefit the national economy in the future, Goldman Sachs analysts predicted in a recent research report. According to a 2023 analysis reported by NBC News, U.S. health care providers wrote more than nine million prescriptions for Ozempic, Wegovy and similar diabetes and obesity drugs during the …

Can weight loss drugs like Ozempic, Wegovy treat other diseases?
1 year, 2 months ago

Can weight loss drugs like Ozempic, Wegovy treat other diseases?

Live Mint  

Researchers are studying prominent weight-loss medicines like Ozempic and Wegovy to find their utility in the treatment of kidney disease, heart failure, neurological disorders, and other ailments. After creating buzz in the weight-loss segment, the medicine may also be useful in reducing the risk of heart stroke, and delaying the progression of kidney disease in diabetes patients, suggests new data, …

Discover Related